Keywords: بقای کل; NSCLC; non-small cell lung cancer; RCTs; randomized controlled trials; OS; overall survival; PFS; progression free survival; ORR; objective response rate; AEs; adverse effects; HR; hazard ratio; RR; relative risk; CI; confidence intervals; FDA; Food and D
مقالات ISI بقای کل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بقای کل; Quality of life; Pancreatic ductal adenocarcinoma; Overall survival; Prognostic indicator; Short Form-12;
Keywords: بقای کل; beta-blockers; cancer recurrence; disease-free survival; overall survival; perioperative;
Keywords: بقای کل; urinary bladder neoplasms; cystectomy; mortality; female; male; CSS; cancer specific survival; DFS; disease-free survival; OS; overall survival; UCB; urothelial bladder cancer;
Keywords: بقای کل; DCM; disulfide crosslinked-micelle; DTX; docetaxel; ESCC; Esophageal squamous cell carcinoma; IHC; immunohistochemistry; TEM; Transmission electron microscope; DLS; dynamic light scatting; CI; combination index; Fa; Fraction affected; FBS; Feutal bovine s
Keywords: بقای کل; Brain neoplasm; Clinical trials; Glioblastoma; Immunotherapeutic; Immunotherapy; Vaccine; APC; Antigen-presenting cell; APVAC; Actively personalized vaccination; BBB; Blood-brain barrier; CMV; Cytomegalovirus; CNS; Central nervous system; CSF; Cerebrosp
Keywords: بقای کل; urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: بقای کل; melanoma; National Cancer Database; stage I melanoma; survival; time to surgery; time to treatment; CoC; Commission on Cancer; LVI; lymphovascular invasion; MM; malignant melanoma; NCDB; National Cancer Database; OS; overall survival; SLNB; sentinel lymph
Keywords: بقای کل; AIHA; autoimmune hemolytic anemia; B2M; β2-microglobulin; BR; bendamustine and rituximab; BTK; Bruton tyrosine kinase; CLL; chronic lymphocytic leukemia; CR; complete remission; FCR; fludarabine; cyclophosphamide; and rituximab; FISH; fluorescence in sit
Keywords: بقای کل; AI; aromatase inhibitor; ASCO; American Society of Clinical Oncology; CDK4/6; cyclin-dependent kinase 4/6; DCIS; ductal carcinoma in situ; DFS; disease-free survival; ER; estrogen receptor; FDA; Food and Drug Administration; HER2; human epidermal growth f
Keywords: بقای کل; Mammalian target of rapamycin; mRCC; Overall survival; Targeted therapy; Vascular endothelial growth factor;
Keywords: بقای کل; ALK; Anaplastic Lymphoma Kinase; CI; Confidence interval; CT; Computerized Tomography; EGFR; Epidermal Growth Factor Receptor; ESMO; European Society of Medical Oncology; 18F-FDG; Fluorodeoxyglucose; IQR; Interquartile range; MATV; Metabolic Active Tumor
Keywords: بقای کل; Cervical reconstructive surgery; Cervical spine tumors; Endometrial cancer; Solitary metastasis; MRI; Magnetic resonance imaging; OS; Overall survival;
Keywords: بقای کل; Lung cancer; Hospital volumes; NCDB; Overall survival;
Keywords: بقای کل; Platelet-to-lymphocyte ratio (PLR); Prognosis; Advanced cancer; Meta-analysis; PLR; platelet-to-lymphocyte ratio; OS; overall survival; PFS; progression-free survival; DFS; disease-free survival; CSS; cancer-specific survival; MeSH; Medical Subject Headin
Keywords: بقای کل; Early rectal cancer; Radical resection; Tumor volume; Overall survival; Recurrence;
Keywords: بقای کل; acral lentiginous melanoma; Asia; metastatic melanoma; nodal melanocytic nevi; sentinel lymph node biopsy; 5-year overall survival; ALM; acral lentiginous melanoma; CLND; completion regional lymph node dissection; EORTC; European Organization for Research
Keywords: بقای کل; Stem cell transplantation; AL amyloidosis; Overall survival; Hematologic response; Melphalan dose;
Keywords: بقای کل; AJCC; American Joint Committee on Cancer; BSC; basaloid squamous cell carcinoma; HR; hazard ratio; OS; overall survival; SEER; Surveillance Epidemiology and End Results; SqCC; squamous cell carcinoma;
Keywords: بقای کل; APC; Antigen presenting cells; CIMP; CpG island methylator phenotype; CIN; chromosomal instability; CRC; colorectal cancer; CTLA-4; cytotoxic T lymphocyte-associated protein 4; DAMPs; danger-associated molecular patterns; FDA; US Food and Drug Administr
Keywords: بقای کل; Surrogate endpoint; Cancer; Overall survival; Meta-analysis; Randomized controlled trial; Systematic review;
Keywords: بقای کل; NSCLC; non-small cell lung cancer; EGFR; epidermal growth factor receptor; OR; odds ratio; HR; hazards ratio; CI; confidence interval; ALK; anaplastic lymphoma kinase; OS; overall survival; NHIS; National Health Insurance Service; NHID; National Health In
Keywords: بقای کل; Cancer; Randomised clinical trials; Systemic inflammation; Glasgow prognostic score; Neutrophil lymphocyte ratio; Overall survival;
Keywords: بقای کل; prostatic neoplasms; castration-resistant; subcutaneous fat; prognosis; tomography; x-ray computed; mortality; ADT; androgen deprivation therapy; ARAT; androgen receptor axis targeted; BMI; body mass index; CCI; Charlson Comorbidity Index; CRPC; castratio
Keywords: بقای کل; 5-FU; 5-fluoro-uracil; AAV; adeno-associated virus; ADAM; ADAM metallopeptidase domain; ADCC; antibody-dependent cell-mediated cytotoxicity; CCL; chemokine (C-C motif) ligand; CD; cluster of differentiation; CTLA-4; cytotoxic T-lymphocyte-associated ant
Keywords: بقای کل; Pancreatic adenocarcinoma; Resectable tumor; Laparotomy; Survival; PDAC; Pancreatic ductal adenocarcinoma; OS; overall survival; PFS; progression free survival; DFS; disease free survival; SMV; Superior mesenteric vein; SMA; Superior mesenteric artery; PV
Keywords: بقای کل; CT; computed tomography; C/T; consolidation/tumor ratio; EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; OS; overall survival; pD-L1; programmed cell death-1 ligand; PET; positron emission tomography; RFS; recurrence-free surviv
Keywords: بقای کل; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: بقای کل; Tongue cancer; Neck dissection; Tumor thickness; Extracapsular spread; Overall survival;
Keywords: بقای کل; Leukemia-free survival; Meta-analysis; Molecular markers; Myelofibrosis; Overall survival;
Keywords: بقای کل; Depth of response; High-risk cytogenetics; LDH; Overall survival; Prognosticator;
Keywords: بقای کل; AE; adverse event; ADR; adverse drug reaction; ANC; absolute neutrophil count; CI; confidence interval; CR; complete remission; CTCAE; common terminology criteria for adverse events; DEX; dexamethasone; ECOG; eastern cooperative oncology group; eCRF; elec
Keywords: بقای کل; ADT; androgen deprivation therapy; AE; adverse event; CRPC; castration-resistant prostate cancer; LHRH; luteinizing hormone-releasing hormone; mCRPC; metastatic CRPC; MFS; metastase-free survival; nmCRPC; non-metastatic CRPC; PFS; progression-free surviva
Keywords: بقای کل; Gastric cancer; Galectins; Overall survival; Meta-Analysis;
Keywords: بقای کل; AML; acute myeloid leukemia; BSC; best supportive care; CI; confidence interval; CIR; cumulative incidence of relapse; CR; complete remission; CRc; composite CR (includes CR, CRi, and CRp); CRi; CR with incomplete hematologic recovery; CRMRDâ; CR with a
Keywords: بقای کل; Hepatocellular carcinoma; Overall survival; Disease-free survival; Outcome; Anatomic resection; Parenchyma-sparing; HCC; Hepatocellular carcinoma; AR; Anatomic resection; PSR; Parenchyma-sparing resection; PSA; Propensity score analysis; DFS; Disease-free
Keywords: بقای کل; ALA; 5-aminolevulinic acid; BM; Brain metastasis; CT; Computerized tomographic; DFI; Disease free interval; EoR; Extent of resection; FDG; Fludeoxyglucose (18F); IONM; intra-operative neurophysiologic monitoring; KPS; Karnofsky performance score; MRI; Mag
Keywords: بقای کل; AE; adverse event; ALK; anaplastic lymphoma kinase; aNSCLC; advanced non-small cell lung cancer; DRG; diagnosis-related group; EGFR; epidermal growth factor receptor; GLM; generalized linear model; HMO; health maintenance organization; HR; hazard ratio; I
Keywords: بقای کل; A; astrocytoma; AA; anaplastic astrocytoma; AO; anaplastic oligodendroglioma; AOA; anaplastic oligoastrocytoma; EGFR; epidermal growth factor receptor; FISH; fluorescence in situ hybridization; MGMT; O6-methylguanine-DNA methyltransferase; MMP9; matrix me
Keywords: بقای کل; CRC; colorectal cancer; GEO; Gene Expression Omnibus; TCGA; The Cancer Genome Atlas; DEGs; differentially-expressed genes; COAD; colon adenocarcinoma; FDR; false-discovery rate; FC; fold change; DAVID; Database for Annotation, Visualization and Integratio
Keywords: بقای کل; adjuvants; immunologic; carcinoma; renal cell; kidney neoplasms; ASSURE; Sunitinib Malate or Sorafenib Tosylate in Treating Patients with Kidney Cancer that was Removed by Surgery; CAIX; carbonic anhydrase IX; DFS; disease-free survival; ECOG; Eastern Coo
Keywords: بقای کل; DSS; disease-specific survival; ESCC; esophageal squamous cell carcinomas; ESD; endoscopic submucosal dissection; HR; hazard ratio; LNM; lymph node metastasis; LVI; lymphovascular invasion; M1; invasion limited to the intraepithelium; M2; invasion limited
Keywords: بقای کل; STIP1; Oncogene; Colorectal cancer; Overall survival; Disease-free survival;
Keywords: بقای کل; DFS; disease-free survival; EGFR; epidermal growth factor receptor; Ex19; exon 19 deletion; Ex21; exon 21 L858R; OS; overall survival; RFS; recurrence-free survival; TKI; tyrosine kinase inhibitor; WT; wild-type;
Keywords: بقای کل; Preconditioning; Intestinal Damage; Graft-Versus-Host Disease; Citrulline; aGvHD; acute graft-versus-host disease; allo-HCT; allogeneic hematopoietic cell transplantation; CI; confidence interval; CIR; cumulative incidence of relapse; DRI; disease risk in
Keywords: بقای کل; DSS; disease-specific survival; LRFS; locoregional recurrence-free survival; NCDB; National Cancer Database; OS; overall survival; RCT; randomized controlled trial; RT; radiation therapy; STS; soft tissue sarcoma; USSC; US Sarcoma Collaborative;
Keywords: بقای کل; microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D
Keywords: بقای کل; National cancer database; Overall survival; Prophylactic cranial irradiation; Radiation; Small cell lung cancer;
Keywords: بقای کل; Time-to-treatment; Disease-free survival; Overall survival; Lung cancer; Curative intent treatment; ACCP; American College of Chest Physicians; BTS; British Thoracic Society; CAD; coronary artery disease; CI; confidence interval; COPD; chronic obstructive
Keywords: بقای کل; Hematopoietic cell transplantation-specific comorbidity index; Stem cell source; Umbilical cord blood transplantation; Nonrelapse mortality; Overall survival;